Susquehanna International Group
EIDX

Susquehanna International Group’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Susquehanna International Group’s Portfolio EIDX Stock Details EIDX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
2020
Q4 		$600K Sell
2020
Q3 		$249K Sell
2020
Q2 		$1.93M Buy
2020
Q1 		$276K Buy
2019
Q4 		– Sell
2019
Q3 		$827K Buy
2018
Q4 		– Sell
2018
Q3 		$117K Buy